Meiqi Wang
Impact in
- Pharmacology top 5%
- Fungal Biology and Applications
- Pharmacological Effects of Natural Compounds
Papers in
- Pharmacology 10
- Plant-based Medicinal Research 6
- Pharmacological Effects of Natural Compounds 6
-
- RNA modifications and cancer 6
- Photosynthetic Processes and Mechanisms 5
- Ginseng Biological Effects and Applications 5
- Cancer-related gene regulation 4
- Co-authors
- Yingying Sun (6 shared papers)Zhen‐Ni Guo (6 shared papers)Hong-Jing Zhu (5 shared papers)Yi Yang (4 shared papers)Fangle Liu (20 shared papers)Chaozhan Lin (20 shared papers)Chenchen Zhu (14 shared papers)Shengyu Zhou (1 shared paper)
- Journals
- Phytomedicine (5 papers)Journal of Ethnopharmacology (4 papers)Frontiers in Immunology (3 papers)Frontiers in Pharmacology (3 papers)Frontiers in Oncology (3 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Meiqi Wang
87 papers receiving 1.5k citations
Meiqi Wang's Hit Papers
Peers
Comparison fields: 5 of 116
- Pharmacology 109
- Complementary and alternative medicine 92
- Cancer Research 163
- Molecular Biology 601
- Pharmacology 128
Countries citing papers authored by Meiqi Wang
This map shows the geographic impact of Meiqi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiqi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiqi Wang more than expected).
Fields of papers citing papers by Meiqi Wang
This network shows the impact of papers produced by Meiqi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiqi Wang. The network helps show where Meiqi Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Meiqi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Remote ischemic conditioning attenuates oxidative stress and inflammation via the Nrf2/HO-1 pathway in MCAO mice Hit paper breakdown → | 2023 | 196 |
| 2 | 2016 | 112 | |
| 3 | 2022 | 101 | |
| 4 | 2020 | 98 | |
| 5 | 2001 | 82 | |
| 6 | 2004 | 82 | |
| 7 | 2023 | 42 | |
| 8 | 2018 | 40 | |
| 9 | 2023 | 39 | |
| 10 | 2021 | 37 | |
| 11 | 2022 | 29 | |
| 12 | 2021 | 25 | |
| 13 | 2021 | 24 | |
| 14 | 2024 | 24 | |
| 15 | 2019 | 23 | |
| 16 | 2021 | 22 | |
| 17 | 2022 | 22 | |
| 18 | 2020 | 21 | |
| 19 | 2021 | 21 | |
| 20 | 2022 | 21 |
About Meiqi Wang
Meiqi Wang is a scholar working on Pharmacology, Molecular Biology, Oncology, Complementary and alternative medicine and Cancer Research, having authored 96 papers that have together received 1.5k indexed citations. Recurring topics across this work include Plant-based Medicinal Research (6 papers), RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (6 papers), Pharmacological Effects of Natural Compounds (6 papers), Photosynthetic Processes and Mechanisms (5 papers), Ginseng Biological Effects and Applications (5 papers), Cancer-related gene regulation (4 papers) and Plant Molecular Biology Research (4 papers). The work is most often cited by research in Pharmacology (109 citations), Complementary and alternative medicine (92 citations), Cancer Research (163 citations), Molecular Biology (601 citations) and Pharmacology (128 citations). Meiqi Wang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Yingying Sun, Zhen‐Ni Guo, Hong-Jing Zhu, Yi Yang, Fangle Liu, Chaozhan Lin, Chenchen Zhu, Shengyu Zhou, Ruoyu Zhao and Peter K.T. Pang. Their work appears in journals such as Phytomedicine, Journal of Ethnopharmacology, Frontiers in Immunology, Frontiers in Pharmacology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.